Skip to main content
Premium Trial:

Request an Annual Quote

PerkinElmer to Acquire Euroscreen Products in Bid to Fatten GPCR Play

NEW YORK (GenomeWeb News) — PerkinElmer today said it plans to acquire privately held GPCR company Euroscreen Products for an undisclosed amount.
 
Euroscreen Products provides GPCR membranes, cell lines, and an aequorin-based cellular assay to drug makers.
 
PerkinElmer CEO Gregory Summe said the acquisition is the company’s “next step in our strategy to build the most comprehensive offering in cellular and drug discovery reagent technologies.”
 
By marketing Euroscreen Products’ AequoScreen platform in particular, Summe added, PerkinElmer would be able to offer its customers a “GPCR screening solution that improves performance and reduces workflow costs, while dramatically increasing lab productivity.”
 
PerkinElmer expects the acquisition to close some time during the first quarter of 2007.
 
Earlier this month PerkinElmer announced its plans to acquire high-throughput screening company Evotec Technologies for €23 million ($30.5 million) in cash.

The Scan

Driving Malaria-Carrying Mosquitoes Down

Researchers from the UK and Italy have tested a gene drive for mosquitoes to limit the spread of malaria, NPR reports.

Office Space to Lab Space

The New York Times writes that some empty office spaces are transforming into lab spaces.

Prion Pause to Investigate

Science reports that a moratorium on prion research has been imposed at French public research institutions.

Genome Research Papers on Gut Microbe Antibiotic Response, Single-Cell RNA-Seq Clues to Metabolism, More

In Genome Research this week: gut microbial response to antibiotic treatment, approach to gauge metabolic features from single-cell RNA sequencing, and more.